Significance of carcinoembryonic antigen mRNA in peritoneal lavage determined by transcription-reverse transcription concerted method in patients with low rectal cancer.
暂无分享,去创建一个
Y. Yatomi | S. Ishihara | K. Hata | K. Murono | K. Yasuda | K. Otani | T. Nishikawa | Toshiaki Tanaka | T. Kiyomatsu | K. Kawai | H. Nozawa | Toshiaki Watanabe | K. Sasaki | M. Kaneko | Yumiko Satoh | M. Kurihara*
[1] Masahiro Yoshida,et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer , 2012, International Journal of Clinical Oncology.
[2] R. Fisker,et al. Diagnostic value of 18F-FDG PET/CT as first choice in the detection of recurrent colorectal cancer due to rising CEA , 2015, Cancer Imaging.
[3] Masahiro Yoshida,et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer , 2011, International Journal of Clinical Oncology.
[4] Y. Yatomi,et al. Detection of carcinoembryonic antigen mRNA in peritoneal lavage by the transcription-reverse transcription concerted method indicates poor prognosis in patients with stage II and III colon cancer. , 2015, Surgery.
[5] C. Claussen,et al. Preoperative assessment of peritoneal carcinomatosis: intraindividual comparison of 18F-FDG PET/CT and MRI , 2013, Abdominal Imaging.
[6] M. Torrisi,et al. Free peritoneal tumor cells detection in gastric and colorectal cancer patients , 2012, Journal of surgical oncology.
[7] D. Sargent,et al. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] S. Kameoka,et al. Clinical use of PET/CT in peritoneal carcinomatosis from colorectal cancer. , 2011, Hepato-gastroenterology.
[9] M. Ducreux,et al. Results of Systematic Second-look Surgery Plus HIPEC in Asymptomatic Patients Presenting a High Risk of Developing Colorectal Peritoneal Carcinomatosis , 2011, Annals of surgery.
[10] M. Hou,et al. Molecular detection of persistent postoperative circulating tumour cells in stages II and III colon cancer patients via multiple blood sampling: prognostic significance of detection for early relapse , 2011, British Journal of Cancer.
[11] Y. Ho,et al. Systematic Review of Prognostic Factors Related to Overall Survival in Patients with Stage IV Colorectal Cancer and Unresectable Metastases , 2011, World Journal of Surgery.
[12] Toshiaki Watanabe,et al. Predictive Value of Cancer Stem-Like Cells and Cancer-Associated Genetic Markers for Peritoneal Recurrence of Colorectal Cancer in Patients after Curative Surgery , 2010, Oncology.
[13] H. Nagawa,et al. Prognostic Value of Peritoneal Cytology and the Combination of Peritoneal Cytology and Peritoneal Dissemination in Colorectal Cancer , 2009, Diseases of the colon and rectum.
[14] Gang Zhou,et al. Antigen expression of human eccrine sweat glands , 2009, Journal of cutaneous pathology.
[15] 大腸癌研究会. Japanese classification of colorectal carcinoma , 2009 .
[16] H. Nagawa,et al. The 4-portal technique decreases adverse effects in preoperative radiotherapy for advanced rectal cancer: comparison between the 2-portal and the 4-portal techniques. , 2007, American journal of surgery.
[17] Toshiaki Watanabe,et al. Rapid genetic diagnosis with transcription-reverse transcription concerted reaction system for peritoneal recurrence and survival in colorectal cancer patients. , 2007, Oncology reports.
[18] M. Solomon,et al. Free Colorectal Cancer Cells on the Peritoneal Surface: Correlation With Pathologic Variables and Survival , 2004, Diseases of the colon and rectum.
[19] U. Metzger,et al. Disseminated Single Tumor Cells as Detected by Real-Time Quantitative Polymerase Chain Reaction Represent a Prognostic Factor in Patients Undergoing Surgery for Colorectal Cancer , 2002, Annals of surgery.
[20] D. Jayne,et al. Peritoneal carcinomatosis from colorectal cancer , 2002, The British journal of surgery.
[21] S. Yasuda,et al. Detection of tumor cells in the portal and peripheral blood of patients with colorectal carcinoma using competitive reverse transcriptase‐polymerase chain reaction , 2001, Cancer.
[22] H. Vetter,et al. Limitations of the reverse transcription-polymerase chain reaction method for the detection of carcinoembryonic antigen-positive tumor cells in peripheral blood. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[23] C. V. D. van de Velde,et al. Micrometastases and survival in stage II colorectal cancer. , 1998, The New England journal of medicine.
[24] R. Low,et al. Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT. , 1997, Radiology.
[25] H. Juhl,et al. Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. , 1997, Cancer research.
[26] M. Kuroki,et al. Carcinoembryonic antigen and related antigens expressed on keratinocytes in inflammatory dermatoses. , 1996, The British journal of dermatology.
[27] Y. Maehara,et al. Lymphatic advancement to peritoneal dissemination and liver metastasis in gastric cancer patients. , 1994, Anticancer research.
[28] L. Sobin,et al. TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.
[29] J. Gamero. Treatment of colorectal cancer. , 1976, JAMA.
[30] H. Bussey,et al. Pelvic Recurrence after Excision of Rectum for Carcinoma , 1963, British medical journal.